Asia

Also, Heuron started expanding to Japan following an exclusive deal to supply its stroke imaging AI.

Dr Ben Ng, chief medical advisor of ORA Group, explains how a hybrid model ensures the highest quality of care delivery.  

Also, Japan has approved one of JLK's stroke imaging AI solutions.

Researchers claim their invention offers a cost-effective and faster way to do single-cell analysis.  

Kauvery Hospital invests in Lifesigns Lifesigns has received undisclosed funding from Kauvery Hospital Group's investment arm, Healthcare Capital.  The new funds, based on a press statement, will "advance Lifesigns’ AI and predictive algorithm capabilities." The company offers an AI-powered remote patient monitoring system that provides alerts and predictive insights.   Lifesigns is now gearing for its next fundraising, where it plans to launch a new product and introduce expansion initiatives.  AI-powered sleep apnoea app now prescribed at major Korean hospital Seoul National University Bundang Hospital is the first among hospitals in South Korea to prescribe an AI-powered mobile application for diagnosing sleep apnoea.  The diagnostic support tool called Apnotrack by medical AI company Asleep records a user's breathing and then uses AI to assess for sleep apnoea.  Asleep claims its app to have comparable performance with at-home polysomnography tests.  Apnotrack received an innovative medical device designation from the South Korean government in 2023 and was approved as a Class II medical device by the Ministry of Food and Drug Safety last year.  TriNetX launches JV with Fujitsu in Japan Global health research network TriNetX has partnered with Fujitsu to launch a joint venture in Japan. The JV, according to a press release, will provide healthcare researchers and pharmaceutical companies in Japan with secure access to big medical and health datasets.  TriNetX runs a self-service data exploration platform for clinical researchers, featuring over 200 million patient records. Its integration with Fujitsu's cloud-based healthcare platform will "create an environment where Japanese medical data, previously underutilised, can be efficiently leveraged for clinical research," said Tatsuki Araki, head of Fujitsu's Healthy Living division.

The Orthopaedic Surgery team has recently received an international patent for the novel AI for robotic total knee replacement. 

Its developer, a spinoff from Nanyang Technological University, Singapore, is looking to raise up to $1.5 million to commercialise their MCI screening tool.

Also, fitness technology company GOQii has introduced an AI-powered post-organ transplant care programme.

PanopticAI also claims to be the first in the city to obtain US FDA clearance for software as a medical device.

The multifunctional biomedical robot can do imaging, sampling, and laser ablation.